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Introduction {#sec1}
============

Craniofacial dysmorphology is a common component of the ciliopathy disease spectrum, but while defective neural crest (NC) cell migration has been implicated in Bardet-Biedl Syndrome (BBS) ([@bib81]), little else is known about the underlying developmental processes in ciliopathy-associated craniofacial defects. Among the more consistent craniofacial phenotypes in ciliopathies is the presence of a high arched palate ([@bib5]). In this condition, the palate is characterized by a pronounced median groove, but the roof of the mouth remains intact across the midline. This condition is often referred to as a "pseudo-cleft." Later in life, a high arched palate is also associated with secondary dental anomalies, such as postnatal gingival swelling and crowding of the molars. These defects can impair speech and complicate intubation, a major concern for craniofacial patients who frequently require multiple surgeries during childhood. Thus, high arched palate has a significant impact on patients' quality of life.

The etiology of high arched palate remains obscure. One long-held hypothesis proposes that the arch arises from a midface hypoplasia causing insufficient maxillary growth and subsequent compression of the upper dental arch ([@bib28; @bib39; @bib75]). However, recent morphometric analyses suggest that this may not be true ([@bib50]). Although a chemically induced rat model has existed for several decades, the embryological progression of the phenotype is unknown ([@bib48]). Surprisingly, no genetic model of high arched palate has yet been reported, so the underlying cellular and anatomical causes remain unknown and developmental hypotheses are untested.

Clinical observations also complicate our picture of high arched palate, as this defect is associated with a variety of seemingly unrelated syndromes ([@bib27; @bib28; @bib39; @bib84]). For example, though rarely mentioned in the literature, high arched palate is a central feature in many ciliopathies, including BBS, oral-facial-digital syndromes (OFD types I and IV), Joubert syndrome, and Sensenbrenner syndrome ([@bib5; @bib28; @bib54; @bib63; @bib70; @bib77]). In fact, 88% of BBS patients present with high arched palate, and many also display associated dental crowding and soft tissue swellings ([@bib5]). High arched palate is also consistently observed in an array of syndromes characterized by dysregulation of fibroblast growth factor (FGF) signaling or downstream components such as the Ras kinase ([@bib23]). Examples include Apert, Crouzon, Muenke, and cardio-facio-cutaneous syndromes ([@bib1; @bib7; @bib28; @bib39; @bib44; @bib68; @bib84]). This finding is curious, because while FGF signals have been implicated in controlling cilium length ([@bib31; @bib56]), there has been no evidence to date suggesting a link between FGF dysregulation syndromes and the ciliopathies.

To characterize ciliopathic craniofacial defects, we examined mice with a mutation in the gene encoding *Fuzzy* (*Fuz*), which has recently emerged as a key regulator of ciliogenesis ([@bib24; @bib61]). Initially described as a *Drosophila* planar cell polarity effector gene ([@bib13]), studies in both *Xenopus* and mice identified Fuz as a central regulator of vertebrate ciliogenesis ([@bib9; @bib24; @bib61]). Consistent with the key role of cilia in Hedgehog (Hh) signaling, disruption of Fuz affects Hedgehog-dependent patterning events in both frogs and mice ([@bib24; @bib61]), and in mice, loss of *Fuz* has been shown directly to disrupt the processing of Gli3 ([@bib29]). Recently, live imaging analyses revealed that Fuz is essential for normal trafficking of the retrograde intraflagellar transport (IFT) machinery in vertebrate cilia; when Fuz is depleted, localization of IFT-A proteins, such as IFT43, is disrupted ([@bib9]). As a consequence, IFT trains become stalled, leading to shortened cilia and impaired signal transduction. Finally, *Fuz* is of particular interest because it is mutated in human patients with birth defects ([@bib71]) and because *Fuz* mutant mice display a variety of craniofacial phenotypes ([@bib88]).

Here, we present the *Fuz* mutant mouse as a useful genetic model for the study of high arched palate. Although current hypotheses suggest that high arched palate arises from constriction of the upper jaw ([@bib28]), our data demonstrate that the primary cause of ciliopathic high arched palate is instead excessive NC producing an enlarged first branchial arch (BA1) and maxillary hyperplasia early in embryogenesis. We have also discovered a surprising mechanistic basis for this phenotype, as we observed a dramatic increase in FGF signaling due to increased cranial *Fgf8* gene expression. Genetic reduction of *Fgf8* rescues the maxillary defects in *Fuz* mutant mice. Finally, we observed a similar maxillary expansion and upregulation of *Fgf8* expression in another ciliopathy mouse model, OFD-1 ([@bib20]). Thus, we have identified dysregulation of FGF function as the cause of facial defects in ciliopathic mutant mice, demonstrating etiological commonalities between two broad categories of human congenital anomalies: the ciliopathies and the FGF-related syndromes.

Results {#sec2}
=======

*Fuz* Mutant Mice Are a Model of High Arched Palate {#sec2.1}
---------------------------------------------------

*Fuz* mutant mice appear to have a cleft secondary palate ([Figures 1](#fig1){ref-type="fig"}A and 1B); however, frontal sections revealed that the palatal shelves were, in fact, not clefted ([Figures 1](#fig1){ref-type="fig"}C--1D′). Instead, in all mutants analyzed, the palatine bones displayed the classic inverted-V shape typical of a high arched palate ([Figures 1](#fig1){ref-type="fig"}D--1D′). Palatal narrowing and palatine bone defects were observed throughout the anterior-posterior extent of the secondary palate in mutants ([Figure S1](#app2){ref-type="sec"} available online). We also observed expanded mesenchyme within the oral cavity in *Fuz* mutant mice ([Figure 1](#fig1){ref-type="fig"}D, "P" in light blue area; [Figure 1](#fig1){ref-type="fig"}D′, gray area). Thus, the maxillary phenotypes of *Fuz* mutant mice bear a striking similarity to the high arched palate reported for human ciliopathy patients ([@bib5; @bib28; @bib79]).

The embryological events leading to high arched palate have not been previously described, so we compared maxillary development in a staged series of wild-type and *Fuz*^−*/*−^ littermates. In controls, the palatal shelves developed bilaterally, growing and extending ventrally into the oral cavity at E13.5 ([Figures 1](#fig1){ref-type="fig"}E and 1E′). The palatal primordia were evident at the appropriate stage in *Fuz* mutants but were displaced medially compared to littermates and did not extend ventrally ([Figures 1](#fig1){ref-type="fig"}H and 1H′, outlined in gray). At E14.5, palatal condensations in controls remained bilateral and were fully extended, flanking the tongue ([Figures 1](#fig1){ref-type="fig"}F-1F′), with the palate fusing by E16.5 ([Figures 1](#fig1){ref-type="fig"}G and 1G′). In mutants, however, the palatal condensations did not extend and instead appeared as one contiguous domain ([Figures 1](#fig1){ref-type="fig"}I--1J′). This medial shift of the palatal shelves was also evident from *Patched1 (Ptc1)* expression, which spans the midline ([Figure S1](#app2){ref-type="sec"}A and S1B). Likewise, ossification of palatine bones was apparent at E17.5 in controls, and in *Fuz* mutants the palatine bones were displaced medially ([Figures 1](#fig1){ref-type="fig"}D and 1D′). Furthermore, analysis by microcomputed tomography (μCT) revealed that the majority of midfacial bones are present and ossifying. Though small and constrained, the mutant palatine bones are roughly normal in shape ([Figures S1](#app2){ref-type="sec"}M--S1M″). These data raised the intriguing possibility that a recognizable palate can form despite an initial failure of shelf outgrowth ([Figures 1](#fig1){ref-type="fig"}H and 1H′).

*Fuz* Mutant Mice Displayed Enlarged Maxillary Processes {#sec2.2}
--------------------------------------------------------

When examined at earlier stages, we found that a larger maxillary process was evident in *Fuz* mutants as early as E9.0 ([Figures 2](#fig2){ref-type="fig"}A and 2B); by e9.5 the maxillary domain is substantially larger (compare [Figures 2](#fig2){ref-type="fig"}C and 2E to [Figures 2](#fig2){ref-type="fig"}D and 2F). Cell numbers were significantly increased in the maxilla, but there was no coincident increase in mitotic cells or change in apoptosis ([Figures 2](#fig2){ref-type="fig"}G and 2H; data not shown). Overall, this developmental progression is strikingly divergent from that underlying traditional cleft palates ([@bib11]), suggesting that the high arched palate, though commonly referred to as a "pseudo-cleft," is unrelated to cleft palate and arises by a distinct developmental mechanism.

Disruption of *Fuz* Leads to Excessive NC {#sec2.3}
-----------------------------------------

We next sought to better understand the developmental origin of this defect. Because the maxillary process normally arises from NC cells emanating from the posterior mesencephalon, we lineage-traced the NC using a *Wnt1-cre* driver to follow cell migration into BA1 ([Figures 2](#fig2){ref-type="fig"}A and 2B′ blue/*lacZ*; [Figures 2](#fig2){ref-type="fig"}I--2L green/green fluorescent protein \[GFP\]) ([@bib16; @bib55; @bib78]). In *Fuz* mutants, we observed an early expansion of cranial NC cells ([Figures 2](#fig2){ref-type="fig"}A and 2B). In [Figure 2](#fig2){ref-type="fig"}B, the rostral extent of this expansion is marked by an asterisk. We also observed a general expansion of midhindbrain streams ([Figures 2](#fig2){ref-type="fig"}A--2B′; note brackets in [Figures 2](#fig2){ref-type="fig"}A and 2B). Most strikingly, dorsal views of these embryos revealed a substantial increase of labeled cells in BA1 and the second branchial arch (BA2) (arrowheads, [Figures 2](#fig2){ref-type="fig"}A′ and 2B′). To confirm the increase in the NC, we isolated E9.25 cranial tissues from a reporter line expressing membrane GFP (*mT/mG*) when crossed to the *Wnt1-cre* driver (schematic in [Figure 2](#fig2){ref-type="fig"}O) ([@bib16; @bib55]). Using flow cytometry, we analyzed *Wnt1-cre* induced GFP-positive cells and found a significant increase in the proportion of NC cells (summarized in [Figure 2](#fig2){ref-type="fig"}P; representative plot per genotype in [Figure 2](#fig2){ref-type="fig"}O). These experiments suggest that the observed maxillary hyperplasia may stem from an excess of NC cells.

Loss of *Fuz* Leads to Disorganized NC Migration {#sec2.4}
------------------------------------------------

In addition to the significant increase in NC cell numbers, the migration of the NC was disrupted in *Fuz* mutant mice. For example, we frequently observed a large proportion of rostral crest cells collecting ectopically in the optic cup regions ([Figure 2](#fig2){ref-type="fig"}B, arrowhead). To examine this at a cellular level, we utilized membrane-bound GFP in *Wnt1-cre; R26*^*mT/mG*^ embryos. Strikingly, three-dimensional confocal imaging revealed that the depth of the migratory streams was far greater in *Fuz* mutants (79 ± 16 μm deep in mutants versus 41 ± 20 μm deep in wild-type embryos; [Figures 2](#fig2){ref-type="fig"}K and 2L). This was surprising, as mesencephalic NC cells should remain adjacent to the epidermal ectoderm, avoiding the underlying mesenchyme ([@bib57]). Furthermore, we noted cells rostral to the trigeminal ganglion in a region that should ordinarily be clear of NC cells (compare [Figure 2](#fig2){ref-type="fig"}I′ to [Figure 2](#fig2){ref-type="fig"}J′).

We had previously shown that morpholino oligonucleotides (MOs) were an effective means to block Fuz function in *Xenopus* ([@bib61]). When we examined expression of *Twist,* a migratory NC marker, following *Fuz* knockdown, we observed aberrant migration of the anterior cranial crest ([Figures 2](#fig2){ref-type="fig"}M and 2N, arrowheads), consistent with the observed craniofacial defects ([@bib61]). In many cases, we noted increased and ectopic migration of the anterior NC into the eye field ([Figure 2](#fig2){ref-type="fig"}N, black arrowhead and inset). Together, these data suggest that *Fuz* plays an evolutionarily conserved role in controlling NC cell contributions to BA1.

Disruption of Cranial Hedgehog Signaling at Early Stages in *Fuz* Mutant Mice {#sec2.5}
-----------------------------------------------------------------------------

We next sought to understand the molecular basis of the maxillary hyperplasia in *Fuz* mutant mice. *Fuz* controls ciliogenesis, and cilia are central to proteolytic cleavage of Gli effector proteins that transduce Hedgehog signals ([@bib22; @bib46; @bib72]). Indeed, loss of *Fuz* leads to defective Hedgehog signaling in the spinal cord and limb ([@bib24; @bib29; @bib61]), and Heydeck et al. showed that, during patterning of the limb, *Fuz* mutation leads to aberrant proteolytic processing of Gli3 ([@bib29]).

However, changes in palatal Hh signaling could not account for the observed craniofacial phenotypes, as the Hh target gene *Ptc1* continues to be expressed in *Fuz* mutant palatal primordia at E14.5 ([Figures S1](#app2){ref-type="sec"}A--S1B′), and unlike the *Fuz* mutation, loss or gain of Hh activation in the palate leads to a true cleft rather than an arched palate ([@bib12; @bib25; @bib34; @bib43; @bib51; @bib66]). Furthermore, *Gli3* mutation also leads to sporadic cleft palate due to obstruction by the tongue ([@bib35]). These data suggest that, if a Gli processing defect is involved, it must occur prior to palate formation.

As it happens, Gli3 plays a crucial role in patterning the tissues that give rise to NC destined for BA1 ([@bib8]). Therefore, we assessed Hh signaling in the cranial regions of e9.0 embryos. We found a dramatic increase of full-length Gli3 in our mutants and a concurrent decrease in the short repressor form of Gli3 ([Figure 3](#fig3){ref-type="fig"}A). We also observed a reduction of Hh target gene expression in cranial tissues ([Figure 3](#fig3){ref-type="fig"}B), which may contribute to the observed NC defect.

Expanded FGF Expression in *Fuz* Mutants {#sec2.6}
----------------------------------------

We then considered molecular changes downstream of the early Gli processing defects in *Fuz*^−/−^ mice. One possibility was that loss of *Fuz* leads to upregulation of Wnt target genes (e.g., [@bib88]); however, we found no changes in levels of activated β-catenin at early stages (e9.0) in *Fuz*^−*/*−^ heads (data not shown). Next, as mentioned, high arched palate is common in FGF hyperactivation syndromes ([@bib26; @bib38; @bib86]). While there is no link between cilia and FGF signal transduction per se, loss of Gli3 can lead to increased *Fgf8* gene transcription, most obviously in the telencephalon ([@bib3; @bib8; @bib14; @bib41; @bib59; @bib65; @bib80; @bib83]). Indeed, a recent report suggests that loss of cilia-dependent signaling can similarly result in *Fgf8* expansion during development of the corpus callosum ([@bib6]).

Therefore, we examined *Fgf8* levels in *Fuz* mutants. Strikingly, at E9.5, *Fgf8* expression was significantly expanded in *Fuz* mutants ([Figures 3](#fig3){ref-type="fig"}D and 3F), though there was minimal difference in mRNA levels prior to e9.0 ([Figure S2](#app2){ref-type="sec"}). *Fgf8* is normally expressed in the midhindbrain boundary, the frontonasal process, and at low levels within the lateral epithelium of the maxillo-mandibular cleft ([Figures 3](#fig3){ref-type="fig"}C and 3C′). In *Fuz* mutants, *Fgf8* expression was expanded in all of these domains, with an anterior expansion from the midhindbrain domain ([Figure 3](#fig3){ref-type="fig"}D, bracket) and a mediolateral expansion within the mandibular and maxillary prominences ([Figures 3](#fig3){ref-type="fig"}D and 3D′). This expansion was maintained in mutant maxilla at E10.5 ([Figure 3](#fig3){ref-type="fig"}F). In addition, we found that *Fuz* knockdown in *Xenopus* also resulted in broader *Fgf8* gene expression, most strikingly in the domain abutting the migratory NC and in the frontal midline ([Figure S3](#app2){ref-type="sec"}).

Key transcriptional targets of FGF signaling, *Erm1* and *Pea3* ([@bib21; @bib64; @bib67]), were strongly upregulated in *Fuz* mutants ([Figures 3](#fig3){ref-type="fig"}I--3J′) including a clear rostral expansion of both messenger RNAs (mRNAs) surrounding the mesencephalon ([Figures 3](#fig3){ref-type="fig"}G--3J, asterisk). Furthermore, both genes were robustly expressed throughout the expanded maxillary primordia, in contrast to the wild-type littermates ([Figures 5](#fig5){ref-type="fig"}H′ and 5J′, arrowhead). Together, these data identify a surprising role for *Fuz* in the regulation of *Fgf8* gene expression, and suggest that an aberrant increase in FGF signaling underlies the craniofacial anomalies in *Fuz* mutant mice.

Fgf8 Heterozygosity Rescues Maxillary Hyperplasia and Palate Defects in *Fuz* Mutant Mice {#sec2.7}
-----------------------------------------------------------------------------------------

Our analysis of *Fuz* mutants suggested that excessive FGF signals drive the maxillary hyperplasia that underlies the observed palate defects. To test this model directly, we asked if decreasing the *Fgf8* gene dose might ameliorate the craniofacial defects in *Fuz* mutants. Using a null allele of *Fgf8*, in which the coding region is replaced with the *lacZ* gene ([@bib37]), we halved the dose of *Fgf8* in *Fuz*^−*/*−^ mice. We observed substantial rescue of maxillary hyperplasia in *Fuz*^−*/*−^*; Fgf8*^*lacZ/+*^ compound mutants (compare *Fuz* mutants in [Figures 4](#fig4){ref-type="fig"}B and 4B′ to rescued embryos in [Figures 4](#fig4){ref-type="fig"}C and 4C′). Heterozygosity of *Fgf8* also rescued the brain overgrowth and ocular phenotypes observed in *Fuz* mutants (compare [Figure 4](#fig4){ref-type="fig"}E to [Figure 4](#fig4){ref-type="fig"}F). Most strikingly, loss of one allele of *Fgf8* restored the e16.5 *Fuz*^−*/*−^ palate to a normal width ([Figures 4](#fig4){ref-type="fig"}H--4K; [Figure S3](#app2){ref-type="sec"}), confirming that the early maxillary phenotype is due in large part to an increase in FGF.

Because the *Fgf8* and NC phenotypes we observed seemed localized to the cranial structures, we hypothesized that phenotypic rescue after decreasing *Fgf8* dose should be specific to the head. Indeed, we found that *Fgf8* heterozygosity had little effect on digit development phenotypes in *Fuz* mutant mice ([Figure S3](#app2){ref-type="sec"}). Together, these data suggest that the proximate cause for craniofacial defects in *Fuz* mutant mice is expanded *Fgf8* expression, while the polydactyly is independent of *Fgf8*, resulting directly from aberrant cilia-mediated Gli3 regulation ([@bib29]).

Conditional Disruption of *Fuz* in the NC Does Not Result in High Arched Palate {#sec2.8}
-------------------------------------------------------------------------------

Our data so far lead us to propose a model in which early dysregulation of cranial Gli processing in *Fuz* mutant mice leads to excessive expression of *Fgf8*, which in turn causes an excess of NC. We further propose that it is this early excess of NC, rather than attendant crest migration defects, that results in maxillary hyperplasia and high arched palate. To test this model, we used the NC-specific *Wnt1-cre* driver to conditionally delete the *Fuz* gene. Notably, specific deletion of *Fuz* in NC cells did not elicit early hyperplasia of the maxillary process or high arched palate ([Figure 5](#fig5){ref-type="fig"}; data not shown). Instead, these animals had a true cleft, indicating that, in the NC, *Fuz* is required only much later for palatal shelf elevation or depression of the tongue. These data suggest that the early maxillary phenotypes in *Fuz* mutant mice result from Fuz requirements in the neural tissue prior to NC induction (see also the model, [Figure 7](#fig7){ref-type="fig"}).

Maxillary Hyperplasia and FGF8 Upregulation in OFD-1 Mice {#sec2.9}
---------------------------------------------------------

We next asked if *Fgf8* misregulation might be a general principle in ciliopathies. We examined the mouse model of OFD syndrome, *Ofd-1* ([@bib20]). OFD patients frequently present with high arched palate ([Figure 6](#fig6){ref-type="fig"}F) ([@bib28; @bib63; @bib79]), and OFD-1 is essential for ciliogenesis and centriole morphology ([@bib20; @bib73]). Importantly, *Ofd-1* mutant animals were strikingly similar to the *Fuz*^−*/*−^ animals, with an enormously enlarged maxillary process and a clear expansion of cranial *Fgf8* expression ([Figures 6](#fig6){ref-type="fig"}A--6D).

Broad Similarity between *Fuz* Mutant Mice and FGF Hyperactivation Syndromes {#sec2.10}
----------------------------------------------------------------------------

Finally, the similarity of palatal phenotypes between OFD patients and patients with FGF hyperactivation syndromes such as Apert ([Figures 6](#fig6){ref-type="fig"}E--6G) suggest that ciliopathic cranial phenotypes stem from excessive FGF signaling. If this were the case, we hypothesized that *Fuz*^−/−^ mice might also display craniosynostosis, another common feature of FGF hyperactivation syndromes. Therefore, we examined skull ossification using Alizarin red staining and found complete synostosis of the coronal sutures in *Fuz* mutant mice, akin to that seen in Apert syndrome ([Figures 6](#fig6){ref-type="fig"}I--6I′, arrowhead). Mutants also displayed other hallmarks of FGF syndromes, including fusion of the cervical vertebra and upper airway anomalies (data not shown) ([@bib2; @bib40; @bib53]). Thus, our data suggest widespread commonalities between ciliopathic craniofacial defects and FGF hyperactivation syndromes.

Discussion {#sec3}
==========

Recent evidence reveals significant roles for cilia in human development and disease. First, mutations in genes known to promote cilia biogenesis and IFT have been implicated in a number of human syndromes ([@bib19]). Second, analysis of animal models suggests that a variety of developmental disorders, including craniofacial dysmorphology, result from defects in ciliary function ([@bib36]). Finally, advances in clinical genomics have improved annotation of disease alleles, subsequently identifying numerous, unclassified syndromes as ciliopathies ([@bib10]). The challenge now is understanding how these seemingly heterogeneous disorders arise ([@bib58]), and our data suggest that commonalities in phenotype are likely to reflect shared signaling events, which converge into shared phenotypes. The results reveal an association between ciliopathies and FGF syndromes, in turn providing insights into the diversity of phenotypes seen in craniofacial anomalies.

We present the *Fuz* mutant as a genetic model of ciliopathic high arched palate and provide experimental evidence of the causes of this defect ([Figure 7](#fig7){ref-type="fig"}). Some aspects of skeletal development in *Fuz* mutants have been previously described; however, those reports focus on mandibular outgrowth ([@bib88]). We propose that the high arched palate arises due to perturbation of facial development in the *Fuz* mutant well before the stages examined previously and that the reported effects on Hh and Wnt signaling are secondary to an earlier developmental defect ([@bib88]).

Our data suggest that early expansion in *Fgf* gene expression drives maxillary phenotypes in the *Fuz* mutant model ([Figure 7](#fig7){ref-type="fig"}), but how does loss of a ciliopathy gene lead to an expansion of FGF signaling? In wild-type embryos, Gli3 repressor is expressed in the midbrain, where it acts as a transcriptional repressor, and indeed, Gli3R normally suppresses *Fgf8* expression in neural tissues, as loss of Gli3 leads to an increase in *Fgf8* ([@bib3]). Gli3 processing from Gli3-A (activator) to Gli3-R (repressor) is thought to occur at the distal tip of the cilium ([Figure 7](#fig7){ref-type="fig"}A) ([@bib17; @bib42; @bib82; @bib85]). This distal tip of the ciliary axoneme is specifically lost in the absence of Fuz ([@bib9]) and likely leads to attenuated Gli3 processing ([Figure 3](#fig3){ref-type="fig"}). Subsequently, loss of Gli3R reduces transcriptional inhibition, permitting expansion of hindbrain fates, and *Fgf8* expression.

Previous studies in chicken embryos have implicated brain-specific *Fgf8* in the control of NC numbers ([@bib15]). How does this occur? DiI labeling has shown that, in mouse, anterior NC destined for BA1 arises from the posterior mesencephalon and rhombomere 1 ([@bib60]). Loss of Hh activity leads to dorsalization or expansion of these structures ([@bib18]), concurrently increasing *Fgf8* expression and the NC domain. As a consequence, increased numbers of NC cells migrate toward BA1, overfilling it and forming enlarged maxillae ([Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}). Subsequently, *Fgf8* is also upregulated in the BA1 epithelium, as well as in the frontonasal prominence ([Figure 3](#fig3){ref-type="fig"}). Following NC migration, the palatal condensation ([Figure 7](#fig7){ref-type="fig"}, red) arises medially, adjacent to *Fgf8* expression domains; in mutants, the grossly enlarged maxillary region causes a medial shift in palatal condensations ([Figure 7](#fig7){ref-type="fig"}).

These findings are significant for exposing an etiological link between the ciliopathies and FGF hyperactivation disorders. Furthermore, our data suggest that the long-held midface hypoplasia model for high arched palate should be revisited ([@bib27; @bib28]). One source of confusion may be the disparity between observations in human patients versus phenotypes associated with mouse models. For example, Snyder-Warwick and colleagues examine palatal development in mice carrying a Crouzon mutation (FGFR2^C342Y^), which causes increased FGF signaling associated with craniosynostosis ([@bib76]). In these mice, heterozygotes, which should mirror the human genotype, have normal palates. Furthermore, homozygotes have a true cleft, mimicking a loss of FGFR2b ([@bib33; @bib66]). This clearly does not model the oral aspects of the human syndrome, as it was noted nearly 40 years ago that true clefts in Crouzon patients were likely to be misdiagnoses ([@bib62]).

Importantly, the relationship between ciliopathy and FGF hyperactivation syndromes is not limited to the palate, as *Fuz* mutant mice also display other manifestations of the FGFR-associated syndromes, such as craniosynostoses, fusions of the cervical vertebrae, and tracheal cartilaginous sleeve ([Figure 6](#fig6){ref-type="fig"}; data not shown). Finally, we note that this relationship is not restricted to animal models, as high arched palate and synostoses also co-occur in the human ciliopathy Sensenbrenner syndrome ([@bib45; @bib70]). Notably, the cilia defects in Sensenbrenner syndrome are caused by mutations in proteins of the retrograde IFT particle, including IFT43 ([@bib4]), and we recently showed that ciliogenesis defects following disruption of *Fuz* stem from a failure of IFT43 trafficking ([@bib9]).

Thus, in summary, our studies of a high arched palate model have revealed that excessive *FGF* transcription and increased NC may be key factors in the poorly understood etiology of ciliopathic craniofacial defects. Furthermore, our report demonstrates that the pathological events underlying this phenotype are surprisingly different from those leading to a traditional cleft palate, raising the possibility that clinical diagnoses and management of high arched palate should also be reconsidered in this developmental and molecular context.

Experimental Procedures {#sec4}
=======================

Mouse Lines {#sec4.1}
-----------

The following mouse lines were used: *Fuz* mutants: *Fuz*^*gt(neo)*^ ([@bib24]); conditional *Fuz* mutants: *Fuz*^*fl/fl*^, which were generated according to standard methods and will be described elsewhere; conditional *Ofd-1* mutants: *Ofd1*^*tm2.1Bfra*^ ([@bib20]); *Fgf8* mutants: *Fgf8*^*lacZ*^ ([@bib37]); *Wnt1-cre* driver: *Tg(Wnt1-cre)11Rth* ([@bib16]); and reporter lines: *R26R*^*mT/mG*^*: GT(Rosa)26Sor*^*tm4(ACTB-tdTomato-EGFP)Luo*^ ([@bib55]) and *R26R*^*lacZ*^: *Gt(ROSA)26Sor*^*tm1Sor*^ ([@bib78]). Genotyping was performed as described in the original publications cited earlier. In all phenotypes depicted, at least four animals per genotype were examined. All animal work was performed in accordance with UK Home Office Regulations.

Western Blotting {#sec4.2}
----------------

Tissues rostral to and including BA1 were dissected from E9.0 embryos. Protein preparations and western blotting were carried out according to established protocols. Primary antibodies used were anti-Gli3 (clone H-280, 1:1,000, Santa Cruz Biotechnology no. sc-20688) and anti-alpha tubulin (clone DM1a, 1:5,000, Sigma T6199). Chemiluminescent signal was visualized using a BioRad ChemiDoc.

Real-Time PCR {#sec4.3}
-------------

Tissues rostral to and including BA1 were dissected from E9.0 embryos. Reverse transcription and cDNA synthesis were carried out according to standard protocols. Real-time PCR (RT-PCR) reactions were performed on a Rotorgene Q 2-series using the following gene-specific primer pairs.*β-actin* (F: CTAAGGCCAACCGTGAAAG, R: ACCAGAGGCATACAGGGACA)*Gli1* (F: CAGGGAAGAGAGCAGACTGAC, R: CGCTGCTGCAAGAGACT)*Patched1* (F: AAGCCGACTACATGCCAGAG, R: AAGGGAACTGAGCGTACTCG)*Fgf8* (F: AGGTCTCTACATCTGCATGAAC, R: TGTTCTCCAGCACGATCTCT)*Erm* (F: TGCCCACTTCATCGCCTGGAC, R: TAGCGGAGAGAGCGGCTCAG)

Staining and Histology {#sec4.4}
----------------------

All mRNA in situ hybridization, immunohistochemistry, β-gal activity, and histological staining were performed according to standard protocols. Mouse and *Xenopus* embryos were collected in cold PBS and fixed overnight in 4% paraformaldehyde or MEMFA, respectively. mRNA in situ hybridization was performed as previously described ([@bib74; @bib87]). The following mRNA probes were used: mouse *Fgf8* ([@bib49]), mouse *erm* ([@bib30]), mouse *Pea3* ([@bib47]), *X. laevis Fgf8* ([@bib52]), and *X. laevis twist* ([@bib32]). Primary antibodies used for immunohistochemistry: anti-rabbit phospho-histone H3 (PH3) (BDH, 1:200) or anti-rabbit β-catenin (Sigma, 1:200). Sections were coverslipped with ProLong Gold antifade reagent with DAPI (Invitrogen, P36931).

Confocal Microscopy and Image Analysis {#sec4.5}
--------------------------------------

To analyze NC migration, whole-mount E9.0 embryos were cleared using 70% glycerol/PBS and mounted on slides. Sagittal confocal z-stacks were obtained using a Leica TCS SP5 DM16000. Image sequences were reconstructed using Imaris image analysis software. Thickness of NC streams were determined by measuring the depth of GFP positive NC cells at three points anterior to the trigeminal ganglion, posterior to the maxillary compartment (outlined in [Figure 3](#fig3){ref-type="fig"}).

μCT {#sec4.6}
---

Specimens were scanned using a GE Explore Locus SP μCT scanner. The specimens were immersed in 20% (w/v) Pluronic F-127 (Sigma) at 4°C and warmed to room temperature for immobilization. Specimens were scanned to produce 8 μm voxel size volumes, using an X-ray tube voltage of 80 kVp and a tube current of 80 μA. An aluminum filter (0.05 mm) was used to adjust the energy distribution of the X-ray source. The specimens were characterized further by making three-dimensional isosurfaces, generated and measured using Microview software (GE).

Flow Cytometry of Embryo Heads {#sec4.7}
------------------------------

Cell purification from embryonic tissues was performed as previously described ([@bib69]). Heads from *Wnt1-cre;* R26^mT/mG^ embryos, as depicted in [Figure 2](#fig2){ref-type="fig"}E, were digested and passed through a 100 μm cell strainer. Flow cytometry was performed using a BD Biosciences FACSAria II cell sorter. Live cells were identified using side scatter and forward scatter (FSC-A), followed by doublet exclusion using forward scatter width against FSC-A. Populations were identified using endogenous expression of GFP and Tomato. All data were analyzed using FlowJo 9.53 (Celeza GmbH).
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![*Fuz* Mutant Mice Are a Model for High Arched Palate\
(A and B) Ventral views of E17.5 palates. Mutants exhibit a narrow palate (arrowheads) and disrupted rugal organization compared to littermates.\
(C and D) Sirius red/alcian blue staining of E17.5 coronal sections. Bilateral palatine bones are formed in both control and mutant, abutting at the midline (black). Mutant palatine bones (Pb) are mediolaterally shortened with an increase in the ventral extension. Note enlarged palatal mesenchyme (P). Molars (M) appear normal.\
(C′ and D′) Schematics depicting skewed palatal anatomy.\
(E--J) Hemotoxylin and eosin staining of coronal sections at indicated stages.\
(E′--J′) Schematics of sections identifying palatal mesenchyme (gray, P), molars (blue and purple, M), and palatal bone condensations (red, Pb). In (H) through (J′), mutant palatal condensations are medially constrained and do not extend into the oral cavity. Palatine bone can be observed in both mutants and controls by E16.5.\
See also [Figure S1](#app2){ref-type="sec"}.](gr1){#fig1}

![Increase in NC in Maxillary Compartment\
*Wnt1-cre*-driven *LacZ* (blue) or *GFP* (green) marks NC contributions.\
(A and B) Lateral views of E9.25 embryos. BA1 and BA2 NC streams are wider compared to controls (B compared to A, yellow bracket). Increased NC disrupts the optic cup (OC) in *Fuz* mutants compared to controls (B compared to A, arrowhead). BA2 NC stream is also increased in size and has failed to migrate as far as BA2 control NC. Mx, maxillary compartment of BA1. OV, optic vesicle.\
(A′ and B′) Dorsal views. Maxillary BA1 is enlarged compared to controls (B compared to A, top arrowhead). BA2 has failed to migrate sufficiently compared to controls (bottom arrowhead).\
(C and D) PH3 staining (green) and DAPI (blue) of E9.0, maxillary compartment. Mutant maxilla is enlarged (white dotted line).\
(E and F) Coronal sections of E10.5 *Wnt1-cre; R26R*^*mT/mG*^; *Fuz*^*+/+*^, or *Wnt1-cre; R26R*^*mT/mG*^*;Fuz*^−*/*−^ maxillae. *Wnt1-cre*-driven membrane-GFP (green) marks NC contributions. Epithelial membrane-Tomato (red) highlights all other tissue derivatives. Mutant maxillae are larger compared to controls. Enlarged maxillae comprise NC-derived mesenchyme.\
(G) Quantification of DAPI-positive cells from representative sections of E9.5 and 10.5 embryos. Note increase in cell number in mutant (red) maxilla compared to wild-type (blue) (p \< 0.004). Error bars indicate SD.\
(H) Quantification of E9.5 maxillary PH3-positive cells compared to total cell number. A significant decrease in the percentage of PH3-positive cells is observed in mutant maxillae (red) compared to controls (blue) (p \< 0.01). Error bars indicate SD.\
(I and J) Single confocal z-sections of *Wnt1-cre; R26R*^*mT/mG*^*;Fuz*^*+/+*^ or *Wnt1-cre; R26R*^*mT/mG*^*;Fuz*^−*/*−^ E9.5 embryos. *Wnt1-cre*-driven membrane-GFP (green) marks NC contributions.\
(I′--J′) Magnified maximum projections of (I) and (J), indicated by a white dotted box. In controls, chains of *Wnt1*-*cre*-driven membrane-GFP-positive NC are observed (yellow arrowheads), with few isolated cells between brain and maxillary compartment (white arrowheads). Isolated NC cells are observed in mutant embryos, indicated by a white arrowhead in (J′), and NC chains are disorganized.\
(K and L) Z-projections of (I′) and (J′). The thickness of NC streams anterior to the prospective trigeminal ganglion is increased in mutants (WT = 41 ± 20 μm thick; mutant = 79 ± 16 μm deep). The immediately underlying membrane-Tomato-positive mesenchymal cells are shown in red, at the bottom of the image. The overlying epithelium is not included. Scale bar, 100 μm. This doubling in thickness is consistent with increased NC invasion into BA1.\
(M and N) *Twist* in situ hybridization of stage 22 embryos injected unilaterally with *Fuz* MO. In controls, *Twist* is expressed in three streams, where the anterior NC stream surrounds the optic placode, indicated in (M) by open arrowhead and inset (bracket). Ectopic *Twist* expression is observed in the optic placode in Fuz morphants, indicated in (N) by arrowhead and inset (bracket).\
(O) Representative epifluorescence image of an E9 *Wnt1-cre; R26*^*mT/mG*^ embryo. Lineage-traced NC cells are labeled GFP (green), and nonrecombined cells are Tomato positive (red). Dashed line illustrates where embryos were bisected caudal to BA1. *Wnt1-cre; R26R*^*mT/mG*^; *Fuz*^*+/+*^, or *Wnt1-cre; R26R*^*mT/mG*^;*Fuz*^−*/*−^ embryo heads were dissociated and GFP positive, Tomato, or double-labeled cells were analyzed by flow cytometry. Representative flow cytometry plots from single E9 *Wnt1-cre; R26*^*mT/mG*^; *Fuz*^*+/+*^, or *Wnt1-cre; R26R*^*mT/mG*^;*Fuz*^−*/*−^ dissociated heads. mG, *Wnt1-cre*-driven membrane-GFP; mT, membrane-Tomato.\
(P) The percentage of *Wnt1-Cre*-driven GFP-positive cells was significantly increased in mutants (79% ± 2%) compared to controls (68% ± 1%) (p = 0.0103). Whiskers represent maximum/minimum data values with median and quartiles represented in the box.](gr2){#fig2}

![Gli3 Processing and Hh and FGF Signaling Are Altered in *Fuz* Mutants\
(A) Western blot analysis of activator and repressor forms of Gli3 (Gli3-L and Gli3-S, respectively) in E9.0 embryos. Increased Gli3-L and reduced Gli3-S was detected in *Fuz*^−*/*−^ embryos in (A), lanes 3--5, compared to controls in (A), lanes 1 and 2. Alpha-tubulin was analyzed as a loading control.\
(B) qPCR of Hh target genes *Patched 1 (Ptc1)* and *Gli1* from E9.0 *Fuz*^*+/+*^ and *Fuz*^−*/*−^ heads. Relative mRNA levels are normalized to *β-actin*. *Ptc1* and *Gli1* are decreased in mutants (red) compared to controls (blue). Whiskers represent maximum/minimum data values with median and quartiles represented in the box.\
(C and D) Lateral views of *Fgf8* expression in E9.0 embryos. *Fgf8* is expressed in the midhindbrain boundary (MHB), frontonasal prominence (FNP), and the BA1 epithelium. In mutants, *Fgf8* expression domains are expanded, indicated by bracket and arrowheads.\
(C′ and D′) Magnified view of BA1 in control and mutant embryos. Dotted line indicates extent of maxillary compartment. Note enlarged maxillary prominence.\
(E and F) Frontal view of *Fgf8* expression in E10.5 embryos. Note mediolateral expansion of maxillary *Fgf8* expression in the mutant, indicated by black arrowhead.\
(G and H) Lateral views of *Erm1* mRNA expression in E9.5 embryos. *Erm1* is expressed in the MHB, FNP, and BA1. In mutants, expression of *Erm1* is expanded ventrally from the MHB (yellow asterisk) and in BA1 (yellow bracket).\
(G′ and H′) Magnified view of BA1. *Erm1* expression is increased in mutant maxillae (yellow arrowheads).\
(I and J) Lateral views of *Pea3* expression in E9.5 embryos. *Pea3* is expressed in the MHB, FNP, and BA1. In mutants, expression of *Pea3* is expanded in BA1 (yellow bracket).\
(I′ and J′) Magnified view of BA1 in control and mutant embryos. *Pea3* expression is increased in mutant maxillae (yellow arrowhead).\
See also [Figure S2](#app2){ref-type="sec"}.](gr3){#fig3}

![*Fgf8* Reduction Rescues Maxillary Hyperplasia and Palatal Width in Compound Mutants\
(A--C) Lateral views of BA1. Maxillary size is expanded in *Fuz*^−*/*−^ mutants in (B) compared to *Fgf8*^*LacZ/+*^ in (A). Maxillary expansion is rescued in *Fuz*^−*/*−^*; Fgf8*^*LacZ/+*^ embryos in (C). *Fgf8* expression is also rescued in compound mutants as β-gal staining reveals similar BA1 epithelial expression in compound mutants and *Fgf8* heterozygotes.\
(A′--C′) Maxillary size is schematized for each genotype.\
(D--F) Lateral view, E12.5. Maxillary size is expanded in mutants in (E) compared to *Fgf8*^*LacZ/+*^ in (D). Maxillary expansion is rescued in *Fuz*^−*/*−^*; Fgf8*^*LacZ/+*^ embryos in (F). Normal *Fgf8* expression (β-gal/blue) is also restored in compound mutants. Brain overgrowth and eye defects are rescued in compound mutants (arrowheads).\
(G--I) Trichrome staining of coronal sections of E16.5 embryos. Palatal width and bone angle are decreased in mutant embryos in (H) compared to controls in (G). Palatal width in *Fuz*^−*/*−^*; Fgf8*^*LacZ/+*^ in (I) appears normal compared to controls in (H). Angle of palatine bone is partially rescued when compared to controls, as shown in (I) compared to (G) and (H).\
(J) Schematic of palatal anatomy.\
(K) Quantification of palatal width in E16.5 *Fuz*^*+/+*^*; Fgf8*^*LacZ/+*^(blue), *Fuz*^−*/*−^*; Fgf8*^*+/+*^ (green), and *Fuz*^−*/*−^*; Fgf8*^*LacZ/+*^(red) embryos. Palatal width is significantly decreased in *Fuz*^−*/*−^*; Fgf8*^*+/+*^ compared to controls, while *Fgf8* heterozygosity rescues palatal width in *Fuz* mutants (p \< 0.0005, one-way analysis of variance). Whiskers represent maximum/minimum data values with median and quartiles represented in the box.\
See also [Figure S3](#app2){ref-type="sec"}.](gr4){#fig4}

![Maxillary Hyperplasia Is Not Due to *Fuz* Function in the NC\
(A and B) Lateral views of E17.5 *Wnt1-cre; Fuz*^*fl/+*^ and *Wnt1-cre; Fuz*^*fl/*−^ embryos. The control embryo in (A) is an albino and lacks pigment in the eye. Arrowheads indicate rostral midline.\
(A′ and B′) Frontal views of E17.5 *Wnt1-cre; Fuz*^*fl/+*^ and *Wnt1-cre; Fuz*^*fl/*−^ embryos. A cleft lip is observed in conditional null embryos \[(B′) compared to (A′), indicated by arrowheads\].\
(A″ and B″) Hemotoxylin and eosin (H&E) staining of coronal sections of E17.5 *Wnt1-cre; Fuz*^*fl/+*^ and *Wnt1-cre; Fuz*^*fl/*−^ embryos. Sections show the anterior secondary palate (P), tongue (T), and molars (M). Palatal shelves are elevated and fused across the midline in control embryos; however, a failure in shelf elevation is observed in *Wnt1-cre; Fuz*^*fl/*−^ embryos \[(B″) compared to (A″), indicated by P\]. The tongue also appears smaller and irregularly shaped in mutants \[(B″) compared to (A″) indicated by T\].](gr5){#fig5}

![*Ofd-1* Mutants Also Show Expanded Maxillary Compartments and Cranial FGF8 Expression Domains\
(A--D) Lateral views of E9.5 embryos showing cranial *Fgf8* mRNA expression domains. The 21 and 23 somite *ofd-1* mutants have enlarged maxillae compared to stage-matched control embryos, indicated by yellow brackets in (B) and (D) compared to (A) and (C), respectively. Maxillary *Fgf8* expression is expanded in mutants compared to controls \[brackets in (B) and (D) compared to (A) and (C), as well as expression in the frontonasal process, indicated by arrowheads\].\
(E--G) OFD-1 and Apert syndrome patients exhibit high arched palate. In (E), a ventral view of a normal palate shows a hard palate with shallow, anterior bilateral rugae and smooth posterior palate (after photo by Millicent Odunze: <http://plasticsurgery.about.com/od/Cleft-Lip-And-Palate/ss/What-Is-A-Cleft-Palate_3.htm>). In (F), a ventral view is shown of the palate from OFD 1 (OFD-1) patient (after [@bib79]; [Figure 2](#fig2){ref-type="fig"}F). (G) shows a ventral view of palate from the Apert syndrome patient (after [@bib68]). Both (F) ciliopathic and (G) FGF-related high arched palates are narrow with a deep medial cleft extending from the anterior hard palate. Rugal-like swellings are more numerous and are extant with the medial cleft. Soft tissue swellings and dental crowding are observed in both groups.\
(H--I′) Loss of Fuz causes coronal craniosynostosis. E17.5 heads stained with Alizarin red. (H) and (I) show dorsolateral views. (H′) and (I′) show dorsal views. Alizarin red negative coronal suture (open arrowheads) separates frontal (F) and parietal (P) bones in wild-type embryos. Coronal suture is absent in mutant embryos (closed arrowheads).](gr6){#fig6}

![Proposed Model for Palatal Defects in *Fuz* Mutants\
(A and B) Schematics depict E8.5 embryos. In Hedgehog signaling, anterograde transport delivers Gli3L (Gli3-activator) to the distal CLAMP-positive ciliary tip (red). Gli3-L is processed into Gli3-S (Gli3 repressor) which undergoes retrograde transport, repressing transcription of targets such as *FGF8*. Anterior NC (dark green) arises from the posterior mesencephalon and anterior hindbrain (purple), and is normally limited by a balance of Hh and FGF signals. NC then migrates into BA1, comprising maxillary and mandibular compartments (Mx and Md, respectively). When Fuz function is lost, ciliary transport and the distal compartment are severely disrupted leading to disruption of Gli processing and an expansion in cranial NC numbers, specifically maxillary NC.\
(C--F) In (C) and (D), schematics depict coronal sections of E9.5 embryos. In coronal sections, the maxilla forms as two bilateral prominences and *Fgf8* is expressed in lateral maxillary epithelia, indicated by purple in (C) through (F). In mutants, the maxillary compartment is enlarged and epithelial *Fgf8* is expanded. In (E) and (F), schematics depict coronal sections of E10.5 embryos. Palatal condensations (red) are medial to *FGF8* expression domains. In wild-type animals, these flank midline mesenchyme but remain separated. In *Fuz* mutants, expansion of *FGF8* causes a medial shift of the palatal condensations. Subsequently, the normal bilateral palatal primordia join at the midline.](gr7){#fig7}
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